{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"fourth_quarter\", filing_year = 2019 and issue_code = \"MMM\" sorted by filing_year descending", "rows": [[2376135, "3a710f65-a4f8-458c-a40f-72e926f48df7", "Q4", "SAYRE CONSULTING, INC", 323216, "ASSOCIATION FOR QUALITY IMAGING", 2019, "fourth_quarter", "MMM", "Outpatient Radiology", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 45000, null, 0, 0, "2019-12-06T18:46:30.550000-05:00"], [2376526, "59443859-42d5-4358-a9af-d8e45c0357c1", "Q4", "HOSPICE COMPASSUS", 401103527, "HOSPICE COMPASSUS", 2019, "fourth_quarter", "MMM", "Medicare hospice, palliative and Medicare Advantage\nPCHETA\nRural Access to Hospice", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", null, 97500, 0, 0, "2019-12-16T09:48:01.427000-05:00"], [2376533, "9dd7bb68-d951-4bbf-8a22-0a5a364e9040", "4A", "HOSPICE COMPASSUS", 401103527, "HOSPICE COMPASSUS", 2019, "fourth_quarter", "MMM", "Medicare hospice, palliative and Medicare Advantage\nPCHETA\nRural Access to Hospice", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", null, 100000, 0, 0, "2019-12-16T10:29:14.790000-05:00"], [2376622, "e9a83118-62b2-450f-a9b4-f52b379df989", "Q4", "NVG, LLC", 76833, "GLOBAL BLOOD THERAPEUTICS", 2019, "fourth_quarter", "MMM", "Issues pertaining to access to care", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-12-18T11:55:53.830000-05:00"], [2376694, "e02d6f28-af20-4936-b9c4-aa324e47cf48", "4T", "INTEREL US", 401104823, "AMERICAN AMBULANCE ASSOCIATION", 2019, "fourth_quarter", "MMM", "Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system. Lobbied on the Medicare Ambulance Access, Fraud Prevention and Reform Act (H.R. 4938) and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3021).", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", 70000, null, 0, 1, "2019-12-20T09:53:21.600000-05:00"], [2376699, "0b87d1da-c6c5-4bf5-927f-e629ba7c9fa4", "4T", "INTEREL US", 401104823, "EMERGENCY DEPARTMENT PRACTICE MANAGEMENT ASSOCIATION", 2019, "fourth_quarter", "MMM", "Provider Enrollment, Medicare and Medicaid, Medicare-Medicaid for Primary Care.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", 30000, null, 0, 1, "2019-12-20T11:08:30.613000-05:00"], [2376751, "cffaf2a1-e3da-4c44-9faa-084dde09ad94", "Q4", "MILLER & WENHOLD CAPITOL STRATEGIES", 307034, "THE TRANSPORTATION ALLIANCE (FORMERLY TAXICAB, LIMOUSINE & PARATRANSIT ASSN.)", 2019, "fourth_quarter", "MMM", "Non-emergency Medical Transportation benefits - proposed cuts.", "Centers For Medicare and Medicaid Services (CMS),General Services Administration (GSA),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-12-23T09:03:20.873000-05:00"], [2376758, "1421227d-67de-4c8e-9b77-32a2b26765d8", "4T", "MR. CARL SCHMID", 51742, "AIDS INSTITUTE", 2019, "fourth_quarter", "MMM", "Medicare Part D, including 6 protected classes and patient out of pocket cap, Medicaid funding, Medicaid repeal and replace efforts, Medicaid drug coverage, including Hepatitis C drugs. Medicare and Medicaid coverage of preventive services, including HIV and Hepatitis testing. Medicaid waivers", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office", 25500, null, 0, 1, "2019-12-23T10:01:26.670000-05:00"], [2376822, "7005fabd-8363-4b14-82f7-f6335b587438", "4T", "THE METROHEALTH SYSTEM", 288236, "THE METROHEALTH SYSTEM", 2019, "fourth_quarter", "MMM", "funding for Medicaid DSH, Medicare site neutrality policies, 340B, Social Determinants of Health", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 1, "2019-12-26T11:02:46.097000-05:00"], [2376833, "e383fc92-62e1-4c5c-b045-13be8c4d8402", "Q4", "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 35968, "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 2019, "fourth_quarter", "MMM", "Medicare coverage and reimbursement challenges related to diagnostic radiopharmaceuticals in the hospital outpatient setting.", "Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE", null, 30000, 0, 0, "2019-12-27T10:28:08.647000-05:00"], [2376867, "bcb9fe7f-80ef-4766-8276-96142e1c309e", "Q4", "THE FEDERAL GROUP, INC.", 51104, "AMERICAN PHYSICAL THERAPY ASSOCIATION", 2019, "fourth_quarter", "MMM", "Physical therapy services within FQHCs and RHCs\nMedicare Part B fee schedule", "HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2019-12-28T11:59:53.923000-05:00"], [2376871, "ed9cea35-20ae-478e-898a-39de145d47de", "Q4", "THE FEDERAL GROUP, INC.", 51104, "AMERICAN COLLEGE OF NURSE-MIDWIVES", 2019, "fourth_quarter", "MMM", "Midwifery coverage and reimbursement policy under Medicare and Medicaid.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-12-28T12:06:38.600000-05:00"], [2376875, "b76f1dfa-9c41-4d49-8eaa-068319c64142", "Q4", "THE FEDERAL GROUP, INC.", 51104, "AMERICAN SOCIETY FOR CLINICAL LABORATORY SCIENCE", 2019, "fourth_quarter", "MMM", "Clinical laboratory services reimbursement under Medicare Part B", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-12-28T12:10:23.543000-05:00"], [2376885, "47778f6b-9a46-4531-8c31-4c89673f9311", "Q4", "THE FEDERAL GROUP, INC.", 51104, "DENTAL TRADE ALLIANCE", 2019, "fourth_quarter", "MMM", "Oral health coverage under the Medicare program and Medicare Advantage", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-12-28T12:52:54.167000-05:00"], [2376914, "338f763c-6539-4a3b-a6e7-f653459d5130", "Q4", "UC HEALTH", 401103195, "UC HEALTH", 2019, "fourth_quarter", "MMM", "Medicaid DSH, surprise billing, transparency, OPPS, IPPS, PFS, Radiation Oncology APM", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2019-12-30T10:07:57.887000-05:00"], [2377006, "b6f5b5bd-9750-451b-88c9-1e9e7a687cc1", "Q4", "MARSHALL BRACHMAN", 6848, "BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM", 2019, "fourth_quarter", "MMM", "monitor post acute care and other site neutral medicare cuts; support legislation for relief of existing physician owned hospitals;monitor legislation affecting hospital not-for-profit status;monitor 340B program;monitor UNOS/HRSA liver transplant protocols", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2020-01-01T10:23:06.613000-05:00"], [2377014, "b5186d63-0479-4007-85e6-393022a02d89", "Q4", "MARSHALL BRACHMAN", 6848, "CARDIOLOGY ADVOCACY ALLIANCE", 2019, "fourth_quarter", "MMM", "oppose cuts to advanced medical imaging;support appropriateness criteria for diagnostic imaging;oppose site neutral cuts;monitor legislation affecting EHR and HIT", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2020-01-01T10:29:10.420000-05:00"], [2377021, "16ba745c-6cb4-4027-9862-396085751cd2", "Q4", "MARSHALL BRACHMAN", 6848, "OKLAHOMA HEART HOSPITAL", 2019, "fourth_quarter", "MMM", "support legislation to allow for growth of hospitals with physician ownership", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2020-01-01T10:35:14.887000-05:00"], [2377095, "e4ab4580-23ce-4a1a-9b18-77383825c8fd", "Q4", "AMERICAN CHIROPRACTIC ASSOCIATION", 1898, "AMERICAN CHIROPRACTIC ASSOCIATION", 2019, "fourth_quarter", "MMM", "HR 1384: Medicare for All Act; ensure chiropractic access\nHR 1346: Medicare at 50 Act; ensure chiropractic access\nS. 470: Medicare at 50 Act; ensure chiropractic access\nHR 3654:Chiropractic Medicare Coverage Modernization Act; providing access to all Medicare-covered services allowed under a chiropractor's licensure", "HOUSE OF REPRESENTATIVES,SENATE", null, 71750, 0, 0, "2020-01-02T11:24:57.127000-05:00"], [2377188, "17745eeb-2b0c-4d34-a11c-ac4b5c27b606", "Q4", "GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS)", 400270236, "GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS)", 2019, "fourth_quarter", "MMM", "Medicaid third party liability; Medicaid and Medicare recovery audit contractor; Medicaid program integrity", "HOUSE OF REPRESENTATIVES,SENATE", null, 90000, 0, 0, "2020-01-02T14:11:06.847000-05:00"], [2377198, "bc3905f2-f63d-422d-a3d6-4688a1f8afab", "Q4", "CAPITOL HILL CONSULTING GROUP", 72053, "AMERICAN ACADEMY OF OPHTHALMOLOGY", 2019, "fourth_quarter", "MMM", "Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-02T14:46:16.510000-05:00"], [2377218, "381ff082-11a6-4059-ae74-602670cb8f94", "Q4", "THE AFFLERBACH GROUP, LLC", 401103165, "NATIONAL ADULT DAY SERVICES ASSOCIATION (NADSA)", 2019, "fourth_quarter", "MMM", "Supporting efforts to modernize Medicare and opposing any efforts to weaken Medicare or Medicaid.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-01-02T15:27:26.287000-05:00"], [2377238, "9471a208-f8d9-4de4-a1ef-51632a0c0bed", "Q4", "LUPIN PHARMACEUTICALS INC", 401104766, "LUPIN PHARMACEUTICALS INC", 2019, "fourth_quarter", "MMM", "The additional CPI penalty on generic drugs within Medicaid.", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR)", null, 109158, 0, 0, "2020-01-02T16:28:39.110000-05:00"], [2377257, "6f87c04a-1366-441e-9904-e6da8406830f", "Q4", "MJWT CONSULTING", 69696, "WELLMED MEDICAL MANAGEMENT INC", 2019, "fourth_quarter", "MMM", "Medicare/Medicare Advantage legislative issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-02T19:56:01.620000-05:00"], [2377460, "96764e68-020a-4da5-81b1-26cac5dc23f1", "4T", "PENN AVENUE PARTNERS", 400918672, "SIGNATURE HEALTHCARE SERVICES, LLC", 2019, "fourth_quarter", "MMM", "Medicaid related program issues.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 1, "2020-01-03T12:40:02.943000-05:00"], [2377542, "e7a9b264-da06-4168-a3f0-18dd75670af2", "Q4", "AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS", 47303, "AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS", 2019, "fourth_quarter", "MMM", "HR 1970 and S. 1544 - The Medicare Access to Radiology Care Act to provide for Medicare reimbursement to supervising radiologists and radiology practices for services performed by radiologist assistants in all health care settings; and other issues related to medical imaging and radiation therapy technical personnel.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 15000, 0, 0, "2020-01-03T14:40:32.190000-05:00"], [2377545, "ebb3f265-3be9-4b4d-a4ad-61febdc98a38", "Q4", "MCDERMOTT WILL & SCHULTE LLP", 24338, "ABIOMED, INC.", 2019, "fourth_quarter", "MMM", "Issues related to Medicare reimbursement and the medical device tax.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-03T14:55:37.123000-05:00"], [2377579, "23232258-1ffe-41cf-83b7-f1b98238adf0", "4T", "MISSION GOVERNMENT RELATIONS (FORMERLY KNOWN AS MUROFF LAW FIRM, LLC)", 314033, "JEVS HUMAN SERVICES", 2019, "fourth_quarter", "MMM", "Medicaid and associated healthcare funding\nworkforce development and training", "HOUSE OF REPRESENTATIVES,SENATE", 10500, null, 0, 1, "2020-01-03T17:43:18.630000-05:00"], [2377619, "c2a38fd3-ba86-42cd-9fda-bf549fa47835", "Q4", "REPUBLIC CONSULTING, LLC", 401016871, "PERSONAL CONNECTED HEALTH ALLIANCE", 2019, "fourth_quarter", "MMM", "Monitor Connected Health Policy.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-04T12:53:08.040000-05:00"], [2377623, "45859dec-4966-4b6a-86db-e39867af923d", "Q4", "REPUBLIC CONSULTING, LLC", 401016871, "WW INTERNATIONAL (FORMERLY KNOWN AS WEIGHT WATCHERS)", 2019, "fourth_quarter", "MMM", "Monitor wellness and obesity treatment policy.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-04T12:54:09.667000-05:00"], [2377682, "ec7b81e2-3b1f-40e0-aeb3-56772b544871", "Q4", "JOHNSTON GROUP, LLC", 400383768, "ASTRIA HEALTH (FORMERLY KNOWN AS SUNNYSIDE COMMUNITY HOSPITAL)", 2019, "fourth_quarter", "MMM", "Impact of sequestration on Medicare reimbursement rates.\nSupport for Critical Access Hospital reimbursement rates without changes.\nSupport for new CMS program that would allow a Critical Access Hospital to transition to a traditional CMS payment model over a ten year period.\nImpact of Section 603 of the Budget Act of 2015 on hospital reimbursement.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-05T16:15:16.980000-05:00"], [2377686, "20a8883e-5791-4522-82ff-3e7b5fe7743a", "Q4", "JOHNSTON GROUP, LLC", 400383768, "ISLAND HOSPITAL", 2019, "fourth_quarter", "MMM", "Impact of sequestration on Medicare reimbursement rates.\nGraduate Medical Education (GME) program establishment.\nSupport for GME incentives to train primary care physicians\nImpact of GME and Direct Medical Education (DME) reimbursement cuts.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-05T16:16:20.247000-05:00"], [2377714, "f998f33b-26ff-432d-8a6e-bfa2c8144e71", "Q4", "CHRISTOPHER MOYER", 401093053, "CAMERON COMPANIES", 2019, "fourth_quarter", "MMM", "Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T.  Reviewed HR 1948, Lymphedema Treatment Act and HR 3235, Access to Genetic Counselor Services Act for potential support.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-06T09:59:01.590000-05:00"], [2377718, "f8b841e8-5da9-41b2-8c32-38a449fcff0f", "Q4", "CAMERON COMPANIES", 401095057, "FOX CHASE CANCER CENTER", 2019, "fourth_quarter", "MMM", "Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.  Reviewed HR 3235, Access to Genetic Counselor Services Act and HR 1948, Lymphedema Treatment Act for potential support.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-06T10:05:07.463000-05:00"], [2377806, "c078db50-82d4-4de1-9464-4e52422bf46f", "Q4", "MWR CONSULTING", 401104301, "UNITEDHEALTH GROUP", 2019, "fourth_quarter", "MMM", "Medicare Advantage", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2020-01-06T12:31:21.837000-05:00"], [2377808, "0d1aa771-4269-45cf-b21a-85f44f30bc94", "Q4", "MWR CONSULTING", 401104301, "HOLLISTER, INC.", 2019, "fourth_quarter", "MMM", "Reimbursement for medical devices under Medicare & Medicaid", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2020-01-06T12:34:23.957000-05:00"], [2377814, "a7aa14c2-edcc-471b-be65-14b713d9a540", "Q4", "MWR CONSULTING", 401104301, "PENN HILL GROUP ON BEHALF OF HOLLISTER, INC.", 2019, "fourth_quarter", "MMM", "Reimbursements for medical products under Medicare/Medicaid", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-06T12:37:28.647000-05:00"], [2377824, "a6c6a88a-d01b-4391-ad51-5e29b4a6b115", "4T", "BALLARD PARTNERS", 401104288, "SENSUS HEALTHCARE", 2019, "fourth_quarter", "MMM", "Healthcare technology regulation - physician reimbursement from Medicare", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 20000, null, 0, 1, "2020-01-06T13:25:41.370000-05:00"], [2377837, "bf7994ac-207b-4b3e-abf4-745bdd5d519b", "Q4", "NETWORK LOBBY FOR CATHOLIC SOCIAL JUSTICE", 63495, "NETWORK", 2019, "fourth_quarter", "MMM", "NETWORK believes that healthcare is a fundamental human right not a privilege for those that can afford coverage. \n\nNETWORK strongly believes that all states should immediately expand Medicaid coverage to provide care for low income Americans. \n\nNETWORK opposes any effort to alter the Medicaid Program by replacing the current entitlement structure to a \"Per Capita Cap or Block Granting\"scheme. Those changes would severely cut federal funding for Medicaid and thus millions of vulnerable Americans would lose coverage. \n\nNETWORK urges the Centers for Medicare and Medicaid Services to prioritize outreach and enrollment efforts for the 2020 open enrollment period. \n\nNETWORK strongly opposes the Department of Health and Human Services guidelines allowing states to condition access to Medicaid on employment.", "Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,U.S. Trade Representative (USTR)", null, null, 0, 0, "2020-01-06T14:34:58.800000-05:00"], [2377889, "06391b32-0b58-435a-af28-b74dcf59a36e", "Q4", "THE KUTLER GROUP", 401103966, "PRIME THERAPEUTICS", 2019, "fourth_quarter", "MMM", "drug pricing issues", "HOUSE OF REPRESENTATIVES,SENATE", 24000, null, 0, 0, "2020-01-06T15:49:40.920000-05:00"], [2377902, "bc7884fc-4ca2-48bd-a13c-711439c1c80c", "Q4", "NVG, LLC", 76833, "NATIONAL BREAST CANCER COALITION FUND", 2019, "fourth_quarter", "MMM", "Metastatic Breast Cancer Access to Care Act (H.R. 2178/S.1374).", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-06T16:21:52.997000-05:00"], [2377943, "bad8cae6-cb05-46b7-b842-a4aa77b51f52", "Q4", "LAW OFFICE OF EDWARD D. KALMAN", 401026894, "CALVARY HOSPITAL", 2019, "fourth_quarter", "MMM", "Medicare advantage coverage", "HOUSE OF REPRESENTATIVES,SENATE", 8705, null, 0, 0, "2020-01-06T19:28:41.597000-05:00"], [2378127, "b5c33974-b2cc-41fa-b177-526a12f92271", "Q4", "OAKLEY CAPITOL CONSULTING LLC", 400858522, "BLANK CHILDREN'S HOSPITAL", 2019, "fourth_quarter", "MMM", "ACE Kids Act, rolled into H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019, maternal and child rural health issues, extenders,", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-01-07T13:50:12.210000-05:00"], [2378129, "e4431f93-d35d-4097-8f62-ae7212b0ee47", "Q4", "OAKLEY CAPITOL CONSULTING LLC", 400858522, "NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS", 2019, "fourth_quarter", "MMM", "ACE Kids Act, Medicaid issues that relate to children of military and veteran families", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-07T13:51:13.807000-05:00"], [2378158, "972cb4a4-7904-438f-84b9-3f6be6887b3e", "Q4", "HORIZON GOVERNMENT AFFAIRS", 315592, "NATIONAL KIDNEY FOUNDATION", 2019, "fourth_quarter", "MMM", "Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-07T14:35:42.363000-05:00"], [2378181, "a503a74e-2d9b-4adb-afb2-2ec515a175ca", "Q4", "AMERICAN CAPITOL GROUP", 305852, "IPSEN BIOPHARMACEUTICALS, INC.", 2019, "fourth_quarter", "MMM", "Medicare Part D issues", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-07T14:50:06.493000-05:00"], [2378188, "7597ea89-7bf6-4819-8969-0efc10ad328a", "Q4", "AMERICAN CAPITOL GROUP", 305852, "HEARTFLOW", 2019, "fourth_quarter", "MMM", "Medicare Reimbursement Issues", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2020-01-07T14:56:16.587000-05:00"], [2378201, "5a584523-6931-4138-9dd7-b09e8f937fa7", "Q4", "CAPITOL IMPACT, LLC", 284471, "THE LIVINGSTON GROUP, LLC (RUSH UNIVERSITY MEDICAL CENTER)", 2019, "fourth_quarter", "MMM", "H.R. 1533/S. 782 - Improving Access to Mental Health Act", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-07T15:23:29.903000-05:00"], [2378239, "fd379ad1-16bb-4778-a8e1-79f26fb088f2", "Q4", "RED+BLUE STRATEGIES", 400693064, "CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS", 2019, "fourth_quarter", "MMM", "H.R. 1865 - Further Consolidated Appropriations Bill for FY 2020- policies focused on disproportionate share hospital payments under Medicaid. \n\nExecutive actions impacting children's health care including potential regulations designed to restructure the Medicaid program. \n\nImplementation issues regarding the ACE Kids Act. \n\n\nH.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Support of the the title including policies focused on improving supports for children with multiple chronic conditions and other critical provisions.\n\nIssues related to helping military families access the health care coverage and treatment for which they are eligible. \n\nIssues related to the treatment of the treatment of Disproportionate Care Hospitals under the Medicaid program.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2020-01-07T17:42:23.887000-05:00"], [2378243, "e8e09163-6dfa-46b4-bc35-785fb587eee5", "Q4", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2019, "fourth_quarter", "MMM", "H.R. 3 - The Lower Drug Costs Now Act of 2019 - Issues related to the role of PBMs in the new structure contemplated by the Act. \n\nHHS rules and regulations related  to the cost of prescription drugs, including, but not limited to,  limiting rebates in the Medicare and Medicaid prescription drug benefits. \n\nLegislative policies and reforms related to Medicare Part B and D specific to the price of prescription medications. \n\nC-THRU Act (S. 476) - Issues related to transparency in the PBM space and ensuring that tools to decrease the cost of prescription medications are maintained.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-07T18:05:27.590000-05:00"], [2378281, "8b8619ca-361d-48ad-8a6f-1619760133db", "Q4", "MEDICAL DEVICE MANUFACTURERS ASSOCIATION", 24794, "MEDICAL DEVICE MANUFACTURERS ASSOCIATION", 2019, "fourth_quarter", "MMM", "Issues relating to Reimbursement of Medical Devices", "Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE", null, 300000, 0, 0, "2020-01-08T10:38:15.340000-05:00"], [2378406, "877d8673-e0a8-4491-a33a-bee4fe39363b", "Q4", "NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC.", 401103322, "NATIONAL ACADEMY OF ELDER LAW ATTORNEYS, INC.", 2019, "fourth_quarter", "MMM", "Senate amendment to H.R. 1865 - National Law Enforcement Museum Commemorative Coin Act [Further Consolidated Appropriations Act, 2020], Division N, Secs. 204 and 205. These provisions extend the Medicaid spousal impoverishment protections for home and community based services and the Money Follows the Person demonstration project.\n\nSupport for:\nS.2000/H.R. 1343, Protecting Married Seniors from Impoverishment Act\nH.R. 1342, the Empower Care Act\n\nPossible legislation to improve state infrastructure for home and community based services.", "HOUSE OF REPRESENTATIVES,SENATE", null, 66000, 0, 0, "2020-01-08T13:23:06.330000-05:00"], [2378447, "981dfb5a-842b-45b4-b683-abe5f9389c61", "Q4", "RED+BLUE STRATEGIES", 400693064, "PEW CHARITABLE TRUSTS", 2019, "fourth_quarter", "MMM", "H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction. \n\nRegulations promulgated by ONC and HHS related to patient matching, interoperability, unique patient identifiers, unique device identifiers and other HIT tools that can support better patient safety in the Medicare and Medicaid systems.  \n\nIssues related to the implementation on the SUPPORT Act (P.L. 115-271) as they relate to curbing opioid abuse and substance use disorder for Medicare beneficiaries.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-08T14:07:31.167000-05:00"], [2378464, "1e2dc264-9f9c-4067-b30d-706c9870e2f7", "Q4", "ARENA STRATEGIES, LLC", 401103555, "INDEPENDENCE BLUE CROSS", 2019, "fourth_quarter", "MMM", "general health care issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-08T14:14:53.647000-05:00"], [2378470, "6959f7c6-9f0d-47ed-8945-73f517dfe683", "Q4", "RED+BLUE STRATEGIES", 400693064, "DAVITA INC.", 2019, "fourth_quarter", "MMM", "Administrative actions and demonstrations related coverning care for people with chronic kidney disease and End Stage Renal Disease (ESRD).\n\nLegislative policies related to ensuring that people living with End Stage Renal Disease (ESRD) who are covered through Medicare Fee for Service (FFS) have the supports and services they need.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2020-01-08T14:17:05.400000-05:00"], [2378480, "52af0ba6-c289-4bb6-9f78-a7139a105f24", "Q4", "RED+BLUE STRATEGIES", 400693064, "BLUE CROSS BLUE SHIELD OF MASSACHUSETTS", 2019, "fourth_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.\n\nHHS proposed rules related the treatment of rebates in Medicare Part D.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-08T14:21:15.047000-05:00"], [2378496, "b232e298-bade-4041-b8b8-123497ded699", "Q4", "RED+BLUE STRATEGIES", 400693064, "THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA", 2019, "fourth_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to the potential creating of a comprehensive Medicare dental benefit.\n\nIssues related to ensuring quality eye and oral health in the Medicaid program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-08T14:48:44.097000-05:00"], [2378499, "eba6e40f-4899-4c48-bad0-4423a3ddcd38", "Q4", "RED+BLUE STRATEGIES", 400693064, "QUEST DIAGNOSTICS INCORPORATED", 2019, "fourth_quarter", "MMM", "H.R. 1865 - Further Consolidated Appropriations Act, 2020 - inclusion of policies regarding data collection from laboratories as dictated by the Protecting Access to Medicare Act (PAMA).\n\nH.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-08T14:54:47.120000-05:00"], [2378501, "ab12be67-c71d-49b5-b4ae-3b02f45e1fb8", "Q4", "RED+BLUE STRATEGIES", 400693064, "BOSTON MEDICAL CENTER", 2019, "fourth_quarter", "MMM", "H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the funding of community health centers and disproportionate care hospitals.  \n\nH.R. 3 - Lower Drug Costs Now Act - Issues related to the 340(b) program and keeping drugs affordable for lower income Americans.\n\nS. 1895 - Lower Health Care Costs Act - Issues related to surprise billing and transparency.\n\nIssues related to expanding the GME program to allow for additional slots to train physicians in the fight against addiction. \n\nPolicies related to social determinants of health (SDH) with a focus on food as medicine, the importance of stable housing and the need for caregiving supports to help patients to get well and stay well. \n\n\nSupport for the reauthorization of a strong, stable Medicaid DSH program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-01-08T14:58:49.267000-05:00"], [2378561, "fdd3248f-b82d-40be-a045-2eb68a20df71", "Q4", "BEN BARNES GROUP LP", 5415, "HUNTSMAN CANCER INSTITUTE", 2019, "fourth_quarter", "MMM", "Medicare Prospective Payment System Exemption", null, null, null, 0, 0, "2020-01-08T16:38:16.103000-05:00"], [2378563, "f542c021-c4b3-46a3-b318-ff40e16e8b8c", "Q4", "TREA SENIOR CITIZENS LEAGUE", 38426, "TREA SENIOR CITIZENS LEAGUE", 2019, "fourth_quarter", "MMM", "Medicare Coverage of Dental Care: H.R. 576 and S. 22, Negotiation of Prescription Drug Prices: S. 99 and H.R. 448 and S. 62 and H.R. 275, Prescription Drug Importation: H.R. 447 and S. 97 and S. 61, Improving Access to Affordable Generics: S. 64.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-01-08T16:40:17.937000-05:00"], [2378569, "4437a187-dab9-4212-a23c-0ee085f5bc66", "Q4", "CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC", 401104914, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2019, "fourth_quarter", "MMM", "coverage and recognition for comprehensive medication management", "Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-08T17:00:31.480000-05:00"], [2378709, "4de8d4a2-414e-4860-aaf7-b13b672d91c5", "Q4", "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 27467, "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 2019, "fourth_quarter", "MMM", "Drug Pricing. H.R. 3, the Lower Drug Costs Now Act:  Proposals authorizing the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufacturers; creating a maximum price for any negotiated drug with an international price index (Average International Market price), requiring drug manufacturers that refuse to negotiation with HHS to pay a non-compliance fee of 65% of the gross sales of the drug in question; requiring drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury; creating a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs.\n\nDrug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019:  Proposals to require pharmaceutical manufacturers to rebate Medicare if they raise prices for drugs covered by Medicare Parts B and D faster than inflation; to establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs; to require Medicare Part D private insurers to pay 60% and, drug manufacturers 20%, of the costs incurred over the out-of-pocket spending cap; to increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions; and to provide state Medicaid programs with increased authority to contain drug prices.\n\nMedicaid Home and Community-Based Services. H.R. 1865:  Proposals to extend permanently the spousal impoverishment protections for Medicaid home and community-based services and to extend permanently Money Follows the Person which provides grants to states for initiatives for people requiring long term care to receive Medicaid services and supports in their homes.\n\nMedicare Prescription Drug Costs. (No bill):  Proposal to require pharmacists to disclose to patients when the the patient copayment exceeds the total cost of the drug to their insurer or pharmacy benefits manager.\n\nMedicare Prescription Drug Costs.  (No bill):  Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. \n\nMedicare Prescription Drug Costs, H.R. 1865:  Proposal to reduce the threshold for entering the catastrophic phase of the Part D benefit to a point where seniors only pay five percent of their drug costs instead of 25%.\n\nMedicare Coverage Expansion. H.R 3, the Lower Drug Costs Now Act: Proposals to expand Medicare coverage to include, vision, dental and hearing benefits. \n\nMedicare Coverage Expansion. H.R. 3, the Lower Drug Costs Now Act: Proposals to expand eligibility for the Low-Income Subsidy and Medicare Savings Program.\n\nMedicare Open Enrollment.  (No bill):  Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a manner that is unbiased toward the traditional Medicare program. \n\nMedigap Reform. H.R. 3, the Lower Drug Costs Now Act: Proposal to improve quality of coverage and access to Medigap by extending guaranteed issue to disabled people and other beneficiaries.\n\nMedicare Enrollment. H.R.  1865:  Proposal to improve beneficiary education tools and extend funding for state health insurance and assistance programs.\n\nReducing Health Care Costs. S. 1895: Proposal to eliminate surprise medical billing including out-of-network charges in emergencies.\n\nInsulin Costs.  H.R. 5444, The Lower Insulin Costs Now Act:  Proposal to require the Food and Drug Administration (FDA) to continue reviewing generic insulin applications after the Agencys currently planned March 2020 cut-off date, i.e., ensuring that any existing generic insulin applications would continue to receive FDA review.  \n\nMedicare Part B Penalty. H.R. 1788: Proposal to cap at two years the period for accrual of the penalty for delayed enrollment into Part B; to prevent individuals with Veterans or retiree coverage or who maintain COBRA coverage through a former employer from having to pay the Part B penalty for the remainder of the time they are covered under Part B.\n\nMedicare Savings Program. H.R. 4671: Proposal to reduce cost-sharing, align income and resource eligibility tests, simplify enrollment, and other program improvements for low-income Medicare beneficiaries.\n\nMedicaid restructuring. (No bill): Proposal by the state of Tennessee to block grant Medicaid.", "Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Treasury, Dept of", null, 220000, 0, 0, "2020-01-09T11:12:27.573000-05:00"], [2378790, "af4f5fa2-2460-419d-bff9-bdf2d6ccce57", "Q4", "HACKENSACK MERIDIAN HEALTH", 401104109, "HACKENSACK MERIDIAN HEALTH", 2019, "fourth_quarter", "MMM", "Medicare reform \nMedicaid expansion and reform \nMedicare and Medicaid Disproportionate Share (DSH) funding \nWage index \nMedicare inpatient and outpatient payment system \nIntegrated health care delivery \nMedical education for teaching hospitals \nHealth information technology (HIT) and telehealth \nBehavioral health \nOn-campus & Off-campus hospital outpatient departments (HOPD) funding \n340B program\nStroke rehabilitation", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2020-01-09T13:59:10.877000-05:00"], [2378799, "145afb3b-c7b4-4627-8afb-1be4646f680c", "Q4", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2019, "fourth_quarter", "MMM", "Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, 144981, 0, 0, "2020-01-09T14:28:19.070000-05:00"], [2378832, "602a1b16-5588-4709-8db0-b9cd822d2296", "Q4", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "GLENMARK PHARMACEUTICALS, INC., USA", 2019, "fourth_quarter", "MMM", "Issues related to Medicaid CPI Penalty.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-01-09T16:00:12.317000-05:00"], [2378837, "d1bd6a7b-09ee-4119-9a08-de14ba59a7b5", "Q4", "ELEKTA, INC.", 401103218, "ELEKTA, INC.", 2019, "fourth_quarter", "MMM", "Issues related to oncology treatment products and services", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 100000, 0, 0, "2020-01-09T16:06:17.640000-05:00"], [2378874, "730bb664-8010-43d1-a41b-857016c0c0bc", "Q4", "LEE CONSULTING, KENNETH G.", 71655, "HEARTFLOW", 2019, "fourth_quarter", "MMM", "Medicare national and local coverage determinations.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-09T16:43:03.847000-05:00"], [2378886, "4928a79a-293e-41fa-ae25-ad68c2829f23", "Q4", "THE SMITH-FREE GROUP, LLC", 35800, "RESCARE INC (DBA BRIGHTSPRING HEALTH SERVICES)", 2019, "fourth_quarter", "MMM", "Discussions involving reauthorization of the Money Follows the Person pilot project\n\nDiscussions involving Medicaid coverage of monitoring technology to improve in-home care\n\nDiscussions involving Medicare prescription drug proposals", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-09T16:49:10.060000-05:00"], [2378936, "b9261f05-aae6-48fc-a797-b83ae472599b", "Q4", "AMERICA'S BLOOD CENTERS", 3834, "AMERICA'S BLOOD CENTERS", 2019, "fourth_quarter", "MMM", "Value of Blood/Reimbursement\nBlood product HCPCS P-code taxonomy\nDate of Service policy applicability to blood centers\nCost of FDA bacterial mitigation strategies guidance", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 20000, 0, 0, "2020-01-10T09:34:25.440000-05:00"], [2379174, "c1215be3-96d3-49cb-91aa-ad6beb665412", "Q4", "I STREET ADVOCATES", 51753, "MONTGOMERY HOSPICE", 2019, "fourth_quarter", "MMM", "Secure adjustment to the hospice wage index for counties that have Metropolitan Divisions", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-10T12:46:49.013000-05:00"], [2379240, "0626772c-3aaf-4c26-89a3-41732009d0d6", "Q4", "THE CJR GROUP, INC.", 288293, "BELLEFAIRE JCB", 2019, "fourth_quarter", "MMM", "FQHC", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-10T13:48:50.197000-05:00"], [2379250, "fdad7d53-66a1-411c-bf5b-3584e341839d", "Q4", "THE CJR GROUP, INC.", 288293, "UNIVERSITY HOSPITALS HEALTH SYSTEM", 2019, "fourth_quarter", "MMM", "CMS rules", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-10T13:54:58.580000-05:00"], [2379309, "6f693270-92b1-4a7b-a050-723c590a8790", "Q4", "DEXCOM, INC.", 401104564, "DEXCOM, INC.", 2019, "fourth_quarter", "MMM", "CMS CGM Reimbursement", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES", null, 57250, 0, 0, "2020-01-10T14:51:11.120000-05:00"], [2379311, "81dc992c-0911-4ffb-aaa7-1bbe2f17785c", "Q4", "I STREET ADVOCATES", 51753, "NATIONAL PARTNERSHIP FOR HOSPICE INNOVATION", 2019, "fourth_quarter", "MMM", "S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; S. 2807, Hospice Care Improvement Act; hospice wage index payment parity issues.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-10T15:00:24.233000-05:00"], [2379317, "2da8f605-4c75-4b2c-ad7c-1b1a2b4d28a0", "Q4", "MCDERMOTT+ LLC", 401103287, "COALITION FOR 21ST CENTURY MEDICINE", 2019, "fourth_quarter", "MMM", "Medicare reimbursement for laboratory-developed tests.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 40000, null, 0, 0, "2020-01-10T15:06:24.950000-05:00"], [2379341, "e74c5790-8a3b-4192-b95b-0906f403897e", "Q4", "MCDERMOTT+ LLC", 401103287, "GILLETTE CHILDREN'S SPECIALTY HEALTHCARE", 2019, "fourth_quarter", "MMM", "Issues of interest to children's hospitals, including CHGME, Medicaid payment and enrollment, and alternative payment models.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-10T15:47:50.453000-05:00"], [2379344, "2f9c3dea-b2a9-44c9-8618-baea839a0e12", "Q4", "AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY", 401103274, "AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY", 2019, "fourth_quarter", "MMM", "Medicaid reform and expansion support \nH.R.1920 Medicaid Bump Act\nFunding for Children's Hospital Graduate Medical Education (CHGME)\nH.R.1329 Medicaid Re-entry Act\nMedicare supervision requirements of non-physician professionals", "Executive Office of the President (EOP),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 10000, 0, 0, "2020-01-10T15:53:08.650000-05:00"], [2379386, "a093722b-ae7e-4176-9b47-c05450f0bb3c", "Q4", "COMMONWEALTH POLICY SOLUTIONS", 401105004, "TRISALUS LIFE SCIENCES", 2019, "fourth_quarter", "MMM", "Medical device development for oncology, drug delivery for oncology", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-10T16:38:02.497000-05:00"], [2379389, "9f71f5cc-7ef7-4a99-a5cb-3a8dd1da4d99", "Q4", "COMMONWEALTH POLICY SOLUTIONS", 401105004, "RARE ACCESS ACTION PROJECT", 2019, "fourth_quarter", "MMM", "Reimbursement for rare disease patient care", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-01-10T16:39:05.420000-05:00"], [2379392, "cd6c9b9a-7165-4a3a-b9ae-608ec36904fa", "Q4", "ACUITY STRATEGIC PARTNERS LLC", 401105363, "AMICUS THERAPEUTICS, INC.", 2019, "fourth_quarter", "MMM", "Reimbursement for rare disease patient care", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-10T16:40:08.237000-05:00"], [2379447, "180fef8f-f01f-413a-8e8e-51f734458484", "Q4", "JAMES EDWARDS", 401027897, "CONSERVATIVES FOR PROPERTY RIGHTS", 2019, "fourth_quarter", "MMM", "Proposed International Pricing Index (IPI) payment model for drugs administered under Medicare Part B\nS. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act)\nReform of drug manufacturer rebates to third parties (e.g., pharmaceutical benefits managers, insurers)\nProposed binding arbitration for enacting government price controls under Medicare Part D\nInflationary penalty as government price controls in Medicare Part D\nS. 1129/H.R. 1384 (Medicare for All Act)\nSingle-payer health care\nH.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act) drug price controls through international reference pricing, direct federal price dictation, confiscatory penalty on the most innovative medicines", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)", 10000, null, 0, 0, "2020-01-11T12:48:39.570000-05:00"], [2379479, "8767f8d7-1024-44f1-bbfc-7b9ad93bce41", "Q4", "HOLLAND & KNIGHT LLP", 18466, "DENVER HEALTH AND HOSPITAL AUTHORITY", 2019, "fourth_quarter", "MMM", "340B Drug Pricing Program; Disproportionate Share Hospital (DSH) Payments; Medicaid reform; Medicare delivery; Community Health Center Funding; Children's Health Insurance Program (CHIP); demonstration program for front-line hospitals; demonstration program for Medicare and Medicaid.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-11T15:25:37.740000-05:00"], [2379493, "f22c19ad-9378-4ae3-b79d-cbfd8214ad48", "Q4", "HOLLAND & KNIGHT LLP", 18466, "FRONT LINE HOSPITAL ALLIANCE", 2019, "fourth_quarter", "MMM", "Pursue demonstration program and modernization of payment streams under Medicare & Medicaid; Pursue pilot program for drug discounts for front line hospitals.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2020-01-11T15:35:07.430000-05:00"], [2379573, "9b0a2f75-6f8e-4aa4-aaf8-43369c70a569", "Q4", "HOLLAND & KNIGHT LLP", 18466, "ALLIANCE FOR REGENERATIVE MEDICINE", 2019, "fourth_quarter", "MMM", "Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; regulatory reimbursement issues; \"Value Based Payment\" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-01-11T18:33:02.977000-05:00"], [2379611, "910c5d72-ab7d-4203-aef2-4c4c22209973", "Q4", "THE D MAJOR GROUP", 401103162, "BANNER HEALTH", 2019, "fourth_quarter", "MMM", "Worked on health policy extensions included in HR 1865, the Further Consolidated Appropriations Act of 2020\" (PL 116-94). Also, advocate for innovative approaches to Medicare Advantage, referred to as \"MA+.\" and rebasing for Sole Community Hospitals.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-12T11:05:16.630000-05:00"], [2379614, "6db3d657-2f2a-49ce-b9c8-595e8913305c", "Q4", "THE D MAJOR GROUP", 401103162, "HEALTH CARE SUPPLY CHAIN ASSOCIATION", 2019, "fourth_quarter", "MMM", "Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related S. 1895, the Lower Health Care Costs Act of 2019; and revised definition of bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-12T11:13:20.037000-05:00"], [2379615, "7b92dd44-1623-4a6b-abf3-7bbae4f648c1", "Q4", "THE D MAJOR GROUP", 401103162, "UNIVERSITY HOSPITALS HEALTH SYSTEM, INC.", 2019, "fourth_quarter", "MMM", "Work on disproportionate share hospital payment proposals, including those extended in H.R. 1865, the Further Consolidated Appropriations Act of 2020. In addition, work on innovative value-based care payment models including accountable care organizations and quality measurement updates. Also, work on children's hospital issues related to bed size flexibility.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-12T11:19:22.143000-05:00"], [2379621, "a5bee077-e9e5-4056-a53e-3f9ba01b1743", "Q4", "THE D MAJOR GROUP", 401103162, "THE DOCTORS HOSPITAL AT RENAISSANCE", 2019, "fourth_quarter", "MMM", "Work on disproportionate share hospital payment issues, including those extended under H.R. 1865, the Further Consolidated Appropriations Act of 2020. In addition, advocate for Stark reform improvements and cap flexibility related to graduate medical education reform.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-12T11:33:30.680000-05:00"], [2379639, "59445792-8391-4f75-b77e-69e1cc51d9f1", "Q4", "THE PETRIZZO GROUP, INC.", 305932, "OMEROS CORPORATION", 2019, "fourth_quarter", "MMM", "Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office", 80000, null, 0, 0, "2020-01-12T16:36:58.427000-05:00"], [2379845, "e31ad8d4-22f4-4517-8255-21cc6b402cfd", "Q4", "ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE)", 400364697, "ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE)", 2019, "fourth_quarter", "MMM", "The Improving Access to Medicare Coverage Act of 2019 (H.R. 1682/S. 753)\nNational Defense Authorization Act of 2018 (H.R. 2810)\nS. AMDT. 621 (H.R. 2810)--Authorization of Physical Therapist Assistants and Occupational Therapy Assistants to Provide Services Under the TRICARE Program\nTrusted Exchange Framework and Common Agreement (TEFCA)\nCONNECT for Health Act of 2017 (H.R. 2556/S. 1016)\nThe Laboratory Access for Beneficiaries (LAB) Act of 2019 (H.R. 3584)\nThe Ensuring Access to Quality Complex Rehabilitation Technology Act of 2019 (H.R. 2408)\nThe Protecting Access to Wheelchairs Act of 2019 (H.R. 2293)\nThe Protecting Beneficiary Access to Complex Rehab Technology Act of 2019 (S. 1223) \nThe Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act of 2019 (H.R.3417)\nThe Creating Opportunities Now and Effective Care Technologies (CONNECT) Act of 2019 (S.2741)\nThe Safeguarding Medicare Access to Respiratory Therapy (SMART) Act of 2019 (H.R.4945)", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 39516, 0, 0, "2020-01-13T10:18:24.067000-05:00"], [2379932, "a7afdb13-5a7a-4a74-8066-db59d17a5f9e", "Q4", "ALZHEIMER'S FOUNDATION OF AMERICA", 323158, "ALZHEIMER'S FOUNDATION OF AMERICA", 2019, "fourth_quarter", "MMM", "H.R. 1873/S. 880 - Improving HOPE for Alzheimer's Act - would support provider education and outreach to improve awareness and utilization of comprehensive Alzheimer's and dementia care planning services covered under Medicare.\nH.R. 1955, the Understanding Appropriate Alzheimer's Care Act of 2019 - Under the bill, CMS would be instructed to conduct a study on antipsychotic prescribing practices in non-nursing home settings.\nS.296/H.R. 2150 - Home Health Care Planning Improvement Act of 2019- allows Medicare payment for home health services ordered by a nurse practitioner, a clinical nurse specialist, a certified nurse-midwife, or a physician assistant.", "Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", null, 41000, 0, 0, "2020-01-13T11:03:33.663000-05:00"], [2379936, "dbc090b0-bd60-4898-98ce-1284ac345c1d", "Q4", "PHYSICIAN ASSISTANT EDUCATION ASSOCIATION", 400482376, "PHYSICIAN ASSISTANT EDUCATION ASSOCIATION", 2019, "fourth_quarter", "MMM", "Medical record documentation\nWorkforce development and clinical training site issues\nIncident-to billing", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", null, 80000, 0, 0, "2020-01-13T11:04:41.180000-05:00"], [2380040, "9dccbdfc-2fdf-463b-87b2-eb0436969da4", "Q4", "I STREET ADVOCATES", 51753, "NATIONAL PARTNERSHIP FOR HOSPICE INNOVATION", 2019, "fourth_quarter", "MMM", "S. 2741/H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; S. 2807, Hospice Care Improvement Act; hospice wage index payment parity issues.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2020-01-13T12:00:31.603000-05:00"], [2380069, "119f2d06-0e97-45e1-b55f-bef2d8600aa0", "Q4", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2019, "fourth_quarter", "MMM", "On December 2, 2019, AACC joined with other members of the healthcare community in writing to the House and Senate in support of H.R.3584, the Laboratory Access for Beneficiaries (LAB) Act, which would delay the reporting of lab financial data for one year and require the Medicare Payment Advisory Committee (MedPAC) to conduced a study on the payment methodology used by the Centers for Medicare Services for reimbursing clinical laboratories. \n\nOn December 5, 2019, AACC met with House and Senate lawmakers and staff in support of H.R.3584, the LAB Act.\n\nOn December 11 & 18, 2019, AACC conducted a grassroots campaign targeted towards House and Senate members in support of H.R.3584.\n\nOn October 3, 2019, AACC conducted a congressional briefing on point of care testing for House and Senate congressional staff.  The association urged the congressional offices to request the Department of Health and Human Services Office of the Inspector General to conduct a study on the quality of testing provided by Certificate of Waiver testing sites under the Clinical Laboratory Improvement Amendments and make recommendations for improvement.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2020-01-13T12:45:58.380000-05:00"], [2380075, "99def460-f141-470f-9b2c-8fe2e20902e4", "Q4", "MCDERMOTT+ LLC", 401103287, "POINT OF CARE TESTING ASSOCIATION", 2019, "fourth_quarter", "MMM", "Medicare payment for clinical laboratory services and implementation of Section 216 of the Protecting Access to Medicare Act of 2014.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2020-01-13T12:51:10.420000-05:00"], [2380090, "62476d0b-c3d2-4b10-8ab6-3d28179eac6b", "Q4", "MARSHALL & POPP, LLC", 401105121, "A PLACE FOR MOM, INC.", 2019, "fourth_quarter", "MMM", "Issues related to senior living referrals and anti-kickback laws.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS)", 90000, null, 0, 0, "2020-01-13T13:01:35.127000-05:00"], [2380126, "2ca239dc-f138-48fd-b92b-01406d0269d3", "Q4", "AMEDISYS, INC.", 401028901, "AMEDISYS, INC.", 2019, "fourth_quarter", "MMM", "Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019; S. 2807 - Hospice Care Improvement Act of 2019.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", null, 240000, 0, 0, "2020-01-13T13:16:27.697000-05:00"], [2380167, "fa312014-7526-4f5d-a4d6-a831d1c6c5b0", "Q4", "INSIGHT PUBLIC AFFAIRS, INC.", 401104735, "COALITION AGAINST PATENT ABUSE", 2019, "fourth_quarter", "MMM", "Educated Congressional staff on potential savings to Medicare and Medicaid by addressing abuses of the patent system.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-01-13T13:35:22.500000-05:00"], [2380172, "b41fc096-1e0b-4100-ab77-c4f67022a061", "Q4", "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 6781, "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 2019, "fourth_quarter", "MMM", "\"Further Consolidated Appropriations Act of 2020,\" (HR 1865) provisions including Medicare and Medicaid extenders, Medicaid Disproportionate Share (DSH) payments, the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and workforce programs; and \"Lower Healthcare Costs Act, (S. 1895) regarding surprise billing, drug pricing and price transparency; 340B Drug Pricing Program; Resident Physicians Shortage Reduction Act of 2019.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 150000, 0, 0, "2020-01-13T13:37:28.963000-05:00"]], "truncated": false, "filtered_table_rows_count": 1490, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "fourth_quarter", "p1": "2019", "p2": "MMM"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": "MMM", "label": "MMM", "count": 1490, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": 2019, "label": 2019, "count": 1490, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&issue_code=MMM", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": "fourth_quarter", "label": "fourth_quarter", "count": 1490, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2019&issue_code=MMM", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM&_facet=filing_type"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM&_facet_date=received_date"}], "next": "2019,2380172", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=fourth_quarter&filing_year=2019&issue_code=MMM&_next=2019%2C2380172&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 3405.6177949532866, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}